SAMSRITA LABS LIMITED Share Price
SAMSRITA
₹---₹-- (--%) Past Year
₹--₹--
LH
What’s in news?
No data available at the moment
Company overview
About
Market cap
| Open₹-- | Close₹-- |
Circuit range₹-- - ₹-- | Day range₹-- - ₹-- | Year range₹-- - ₹-- |
Volume-- | Avg. traded₹-- | Revenue (12m)₹NaN undefined |
SAMSRITA LABS LIMITEDSamsrita Labs Ltd is an India-based biopharma company. The Company is engaged activities, such as trading, exports and imports, manufacturing of bulk drugs, APIs, Specialty drugs, research and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease.
Read more
SAMSRITA LABS LIMITED Key indicators
52 week high₹-- | 52 week low₹-- | P/E ratio |
P/B ratio | ROE-- | ROCE-- |
Dividend yield-- | Debt/Equity ratio | EPS |
Learn more
Featured in
Fundamentals
Financial ratios
Operating profit margin-- | Net profit margin-- |
ROE-- | ROA-- |
ROCE-- |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
SAMSRITA LABS LIMITED Share Price history
Day | Open | Close | Day’s change |
---|
Events
No data available at the moment
More
Similar stocks
People also bought
Investment calculators
Upcoming IPOs
No data available at the moment